Avanos Medical (AVNS) Change in Receivables (2016 - 2026)
Avanos Medical's Change in Receivables history spans 13 years, with the latest figure at -$8.1 million for Q4 2025.
- On a quarterly basis, Change in Receivables fell 2600.0% to -$8.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$30.9 million, a 568.18% decrease, with the full-year FY2025 number at -$30.9 million, down 568.18% from a year prior.
- Change in Receivables hit -$8.1 million in Q4 2025 for Avanos Medical, down from -$700000.0 in the prior quarter.
- Over the last five years, Change in Receivables for AVNS hit a ceiling of $18.7 million in Q4 2022 and a floor of -$26.2 million in Q1 2023.
- Historically, Change in Receivables has averaged -$1.4 million across 5 years, with a median of -$500000.0 in 2024.
- Biggest five-year swings in Change in Receivables: surged 6133.33% in 2022 and later tumbled 2600.0% in 2025.
- Tracing AVNS's Change in Receivables over 5 years: stood at $300000.0 in 2021, then surged by 6133.33% to $18.7 million in 2022, then crashed by 148.13% to -$9.0 million in 2023, then surged by 96.67% to -$300000.0 in 2024, then tumbled by 2600.0% to -$8.1 million in 2025.
- Business Quant data shows Change in Receivables for AVNS at -$8.1 million in Q4 2025, -$700000.0 in Q3 2025, and $3.0 million in Q2 2025.